Picture of Alpine Immune Sciences logo

ALPN — Alpine Immune Sciences News Story

0.000.00%
us flag iconLast trade - 00:00
HealthcareAdventurousLarge CapHigh Flyer

Brief: Alpine Immune Sciences Reports First Quarter 2022 Results

May 12 (Reuters) - Alpine Immune Sciences Inc  ALPN.O :
    * ALPINE IMMUNE SCIENCES PROVIDES CORPORATE UPDATE AND
REPORTS
FIRST QUARTER 2022 FINANCIAL RESULTS
    * ALPINE IMMUNE SCIENCES INC- AS OF MARCH 31, 2022, WE HAD
CASH,
CASH EQUIVALENTS, AND INVESTMENTS TOTALING $219.1 MILLION
    * ALPINE IMMUNE SCIENCES INC- EXPECTS THAT ITS CURRENT CASH
RESOURCES WILL BE SUFFICIENT TO FUND ITS PLANNED OPERATIONS INTO
2024
    * ALPINE IMMUNE SCIENCES INC - QTRLY LOSS PER SHARE $0.25
    * ALPINE IMMUNE SCIENCES INC- COLLABORATION REVENUE FOR Q1
ENDED
MARCH 31, 2022 WAS $13.6 MILLION COMPARED TO $3.2 MILLION FOR Q1
ENDED MARCH 31, 2021

Source text for Eikon:  ID:nBw9xg5Ksa 
Further company coverage:  ALPN.O 

 ((Reuters.Briefs@thomsonreuters.com;))

Recent news on Alpine Immune Sciences

See all news